147 related articles for article (PubMed ID: 9029102)
21. XylS-Pm promoter interactions through two helix-turn-helix motifs: identifying XylS residues important for DNA binding and activation.
Domínguez-Cuevas P; Marín P; Marqués S; Ramos JL
J Mol Biol; 2008 Jan; 375(1):59-69. PubMed ID: 18005985
[TBL] [Abstract][Full Text] [Related]
22. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
Smith KD; Lutz CT
J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
[TBL] [Abstract][Full Text] [Related]
23. Several common HLA-DR types share largely overlapping peptide binding repertoires.
Southwood S; Sidney J; Kondo A; del Guercio MF; Appella E; Hoffman S; Kubo RT; Chesnut RW; Grey HM; Sette A
J Immunol; 1998 Apr; 160(7):3363-73. PubMed ID: 9531296
[TBL] [Abstract][Full Text] [Related]
24. The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length.
Bell MJ; Burrows JM; Brennan R; Miles JJ; Tellam J; McCluskey J; Rossjohn J; Khanna R; Burrows SR
Mol Immunol; 2009 May; 46(8-9):1911-7. PubMed ID: 19157553
[TBL] [Abstract][Full Text] [Related]
25. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
[TBL] [Abstract][Full Text] [Related]
26. HLA-B15: a widespread and diverse family of HLA-B alleles.
Hildebrand WH; Domena JD; Shen SY; Lau M; Terasaki PI; Bunce M; Marsh SG; Guttridge MG; Bias WB; Parham P
Tissue Antigens; 1994 Apr; 43(4):209-18. PubMed ID: 7521976
[TBL] [Abstract][Full Text] [Related]
27. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
[TBL] [Abstract][Full Text] [Related]
28. Pocketcheck: updating the HLA class I peptide specificity roadmap.
Huyton T; Ladas N; Schumacher H; Blasczyk R; Bade-Doeding C
Tissue Antigens; 2012 Sep; 80(3):239-48. PubMed ID: 22803829
[TBL] [Abstract][Full Text] [Related]
29. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and structural impact of natural polymorphism in the HLA-A3 superfamily.
Li L; Bouvier M
Mol Immunol; 2005 Jul; 42(11):1331-44. PubMed ID: 15950729
[TBL] [Abstract][Full Text] [Related]
31. Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis.
Lamas JR; Paradela A; Roncal F; López de Castro JA
Arthritis Rheum; 1999 Sep; 42(9):1975-85. PubMed ID: 10513815
[TBL] [Abstract][Full Text] [Related]
32. Identification of three novel HLA class I alleles: HLA-B*3928, HLA-B*400104 and HLA-B*4437.
Velickovic ZM; Dodd R; Velickovic M; Hersee J; Le T; Taverniti A; Wallace R; Dunckley H
Tissue Antigens; 2004 Oct; 64(4):509-11. PubMed ID: 15361131
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cell recognition of HLA class I molecules.
Brooks AG; Boyington JC; Sun PD
Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
[TBL] [Abstract][Full Text] [Related]
34. Identification of three novel HLA class I alleles: HLA-A*0261, HLA-B*1585 and HLA-B*1587.
Lee KW; Cho S
Tissue Antigens; 2005 May; 65(5):493-6. PubMed ID: 15853906
[TBL] [Abstract][Full Text] [Related]
35. HLA-DR beta-chain polymorphism. Second domain polymorphism reflects evolutionary relatedness of alleles and may explain public serologic epitopes.
Gorski J
J Immunol; 1989 Jul; 143(1):329-33. PubMed ID: 2471740
[TBL] [Abstract][Full Text] [Related]
36. Amino acid determinants of beta-hairpin conformation in erythropoeitin receptor agonist peptides derived from a phage display library.
Skelton NJ; Russell S; de Sauvage F; Cochran AG
J Mol Biol; 2002 Mar; 316(5):1111-25. PubMed ID: 11884148
[TBL] [Abstract][Full Text] [Related]
37. The Bw4/Bw6 difference between HLA-B*0802 and HLA-B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells.
Arnett KL; Huang W; Valiante NM; Barber LD; Parham P
Immunogenetics; 1998 Jun; 48(1):56-61. PubMed ID: 9601944
[TBL] [Abstract][Full Text] [Related]
38. In silico analysis of peptide binding features of HLA-B*4006.
Gadewal NS; Joshi NN
Indian J Exp Biol; 2012 Feb; 50(2):93-100. PubMed ID: 22670471
[TBL] [Abstract][Full Text] [Related]
39. Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.
O'Connor GM; Vivian JP; Widjaja JM; Bridgeman JS; Gostick E; Lafont BA; Anderson SK; Price DA; Brooks AG; Rossjohn J; McVicar DW
J Immunol; 2014 Mar; 192(6):2875-84. PubMed ID: 24563253
[TBL] [Abstract][Full Text] [Related]
40. The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C.
Barber LD; Percival L; Valiante NM; Chen L; Lee C; Gumperz JE; Phillips JH; Lanier LL; Bigge JC; Parekh RB; Parham P
J Exp Med; 1996 Aug; 184(2):735-40. PubMed ID: 8760827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
